Elite Pharmaceuticals Inc. (ELTP)

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q3 2018 Results - Earnings Call Transcript
Feb. 12, 2018 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q2 2018 Results - Earnings Call Transcript
Nov. 11, 2017 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q1 2018 Results - Earnings Call Transcript
Aug. 12, 2017 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q4 2017 Results - Earnings Call Transcript
June 15, 2017 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q3 2017 Results - Earnings Call Transcript
Feb. 13, 2017 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q2 2017 Results - Earnings Call Transcript
Nov. 10, 2016 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q1 2017 Results - Earnings Call Transcript
Aug. 16, 2016 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q4 2016 Results - Earnings Call Transcript
June 20, 2016 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q3 2016 Results - Earnings Call Transcript
Feb. 11, 2016 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q3 2015 Results - Earnings Call Transcript
Nov. 10, 2015 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceutical's (ELTP) CEO Nasrat Hakim on Q1 2016 Results - Earnings Call Transcript
Aug. 11, 2015 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceutical's (ELTP) CEO Nasrat Hakim on Q4 2015 Results - Earnings Call Transcript
June 16, 2015 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q3 2015 - Earnings Call Transcript
Feb. 18, 2015 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q2 2015 Results - Earnings Call Transcript
Nov. 19, 2014 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q1FY2015 Results - Earnings Call Transcript
Aug. 18, 2014 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q4 2014 Results - Earnings Call Transcript
July 1, 2014 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' CEO Discusses F3Q2014 Results - Earnings Call Transcript
Feb. 18, 2014 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals - Q2 2014 Earnings Call Transcript
Nov. 18, 2013 | Price: Free! | Source: Earnings Impact

Elite Pharmaceuticals - Q1 2014 Earnings Call Transcript
Aug. 15, 2013 | Price: Free! | Source: Earnings Impact

Elite Pharmaceuticals' CEO Discusses 2Q 2013 Results - Earnings Call Transcript
Aug. 15, 2013 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' CEO Discusses F4Q2013 Results - Earnings Call Transcript
June 24, 2013 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' CEO Discusses F3Q13 Results - Earnings Call Transcript
Feb. 19, 2013 | Price: Free! | Source: Seeking Alpha

Recent filings

Elite Pharmaceuticals, Inc. Reports Financial Results For The Third Quarter Of Fiscal Year 2018 - Feb. 9, 2018

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2018 Ended December 31, 2017 - Feb. 9, 2018

Elite Pharmaceuticals And Sungen Pharma File Anda - Feb. 8, 2018

Elite Pharmaceuticals and SunGen Pharma File ANDA - Feb. 8, 2018

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Third Quarter Financial Results on February 12, 2018 - Feb. 7, 2018

Elite Pharmaceuticals Reports Positive Topline Results From Sequestox™ Pilot Study - Jan. 31, 2018

Elite Pharmaceuticals Reports Positive Topline Results From Pivotal Bioequivalence Studies For An Extended-Release Generic - Jan. 10, 2018

Elite Pharmaceuticals Reports Positive Topline Results from Pivotal Bioequivalence Studies for an Extended-Release Generic - Jan. 10, 2018

Elite Pharmaceuticals Announces FDA Approval of Phendimetrazine Tartrate Tablets USP - Jan. 2, 2018

Elite Pharmaceuticals Announces Fda Approval Of Phendimetrazine Tartrate Tablets Usp - Jan. 2, 2018

On December - Dec. 19, 2017

Elite Pharmaceuticals Inc. Just Filed Its Quarterly Report: NOTE 22. SUBSEQUE... - Nov. 9, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2018 Ended September 30, 2017 - Nov. 9, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results For The Second Quarter Of Fiscal Year 2018 - Nov. 9, 2017

CORRECTING and REPLACING – Elite Pharmaceuticals, Inc. - Nov. 7, 2017

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Second Quarter Financial Results on September 10, 2017 - Nov. 7, 2017

Confidential treatment order - Oct. 11, 2017

Elite Pharmaceuticals Files ANDA for Oxycodone Hydrochloride Extended Release - Sept. 20, 2017

Caution Concerning Forward Looking - Sept. 7, 2017

Elite Pharmaceuticals to Present ELI-200 (SequestOx™) Data at PAINWeek 2017 National Conference - Aug. 30, 2017

Elite Pharmaceuticals Inc. Just Filed Its Quarterly Report: The following i... - Aug. 9, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2018 Ended June 30, 2017 and Provides Conference Call Information - Aug. 9, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results For The First Quarter Of Fiscal Year 2018 Ended June 30, 2017 And Provides Conference Call Information - Aug. 9, 2017

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss First Quarter Financial Results on August 10, 2017 - Aug. 8, 2017

Elite Announces Co-Development of Four Additional Products with SunGen Pharma - July 28, 2017

Elite Pharmaceuticals: Elite Announces Co-Development Of Four Additional Products With Sungen Pharma - July 28, 2017

Elite Announces New Development and License Agreement with SunGen Pharma LLC - July 12, 2017

Confidential treatment order - July 12, 2017

Elite Pharmaceuticals: Elite Announces New Development And License Agreement With Sungen Pharma Llc - July 12, 2017

Elite Pharmaceuticals Reports Topline Results From A Pivotal Fed Bioequivalence Study For Sequestox™ - July 7, 2017

Elite Pharmaceuticals Reports Topline Results from a Pivotal Fed Bioequivalence Study for SequestOx™ - July 7, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results For The Fiscal Year Ended March 31, 2017 And Provides Conference Call Information - June 14, 2017

Elite Pharmaceuticals Inc. Just Filed Its Annual Report: Earnings (Loss) P... - June 14, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2017 and Provides Conference Call Information - June 14, 2017

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results on June 15, 2017 - June 13, 2017

Elite Pharmaceuticals Inc. Just Received a Notice of Effectiveness - June 5, 2017

Elite Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - June 5, 2017

Registration statement under Securities Act of 1933 - June 2, 2017

Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology - May 31, 2017

Elite Pharmaceuticals’ SequestOx™ Study Results Expected in July - May 25, 2017

Elite Pharmaceuticals Acquires Trimipramine Anda - May 22, 2017

Elite Pharmaceuticals Acquires Trimipramine ANDA - May 22, 2017

Registration statement under Securities Act of 1933 - May 10, 2017

Notice of Exempt Offering of Securities, item 06b - May 10, 2017

Major owner of Elite Pharmaceuticals Inc. just disposed of 158,017,321 shares - May 3, 2017

Entry into a Material Definitive - May 2, 2017

Entry into a Material Definitive - May 1, 2017

Entry into a Material Definitive - April 28, 2017

Elite Pharmaceuticals Files ANDA for Pain Product - April 4, 2017

Elite Pharmaceuticals, Inc. Initiates Pivotal Bioequivalence Fed Study for Reformulated SequestOx™ - March 13, 2017

Elite Pharmaceuticals Inc. director just picked up 88,679 shares - Feb. 27, 2017

Major owner of Elite Pharmaceuticals Inc. just picked up 2,216,992 shares - Feb. 27, 2017

Elite Pharmaceuticals Inc. director just picked up 133,019 shares - Feb. 27, 2017

Elite Pharmaceuticals Inc. director just picked up 88,679 shares - Feb. 27, 2017

Elite Pharmaceuticals Inc.'s SVP of Operations just picked up 110,849 shares - Feb. 27, 2017

Elite Pharmaceuticals Inc. director just picked up 68,518 shares - Feb. 27, 2017

Elite Pharmaceuticals Inc. director just picked up 72,040 shares - Feb. 27, 2017

Elite Pharmaceuticals, Inc. Reports Results for Third Quarter of Fiscal Year 2017 - Feb. 9, 2017

Elite Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Feb. 9, 2017

Elite Pharmaceuticals, Inc. Reports Results For Third Quarter Of Fiscal Year 2017 - Feb. 9, 2017

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss 3rd Quarter 2017 Financial Results on February 13, 2017 - Feb. 7, 2017

Elite Reports On SequestOx™ FDA End-of-Review Meeting - Jan. 23, 2017

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study for a Generic OxyContin® - Jan. 17, 2017

Elite Pharmaceuticals: Elite Provides Update On Sequestox™ New Drug Application - Dec. 22, 2016

Confidential treatment order - Dec. 22, 2016

Elite Provides Update on SequestOx™ New Drug Application - Dec. 22, 2016

Elite Pharmaceuticals Files ANDA for Hydrocodone and Acetaminophen Combo - Dec. 12, 2016

Elite Pharmaceuticals: As Of Close Of Business On - Nov. 17, 2016

Elite Pharmaceuticals, Inc. And Subsidiaries PART II – OTHER INFORMATION - Nov. 17, 2016

Elite Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Nov. 9, 2016

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2017 and Provides Conference Call Information - Nov. 9, 2016

Elite Pharmaceuticals Inc. Just Filed Its Quarterly Report: Earnings (Loss) P... - Nov. 9, 2016

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss 2nd Quarter 2017 Financial Results on November 10, 2016 - Nov. 7, 2016

Entry Into A Material Definitive - Sept. 1, 2016

Elite Pharmaceuticals: Elite Announces Development And License Agreement With Sungen Pharma Llc - Aug. 31, 2016

Elite Announces Development and License Agreement with SunGen Pharma LLC - Aug. 29, 2016

Elite Announces Development and License Agreement with SunGen Pharma LLC - Aug. 29, 2016

Major owner of Elite Pharmaceuticals Inc. just picked up 142,857,143 shares - Aug. 19, 2016

Elite Pharmaceuticals files ANDA to Market Generic Percocet - Aug. 10, 2016

Elite Pharmaceuticals, Inc. Reports Financial Results For The First Quarter Of Fiscal Year 2017 And Provides Conference Call Information - Aug. 9, 2016

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2017 and Provides Conference Call Information - Aug. 9, 2016

Elite Pharmaceuticals Inc. Just Filed Its Quarterly Report: Earnings (Loss) P... - Aug. 9, 2016

Elite Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Aug. 9, 2016

OTCQB Certification - Aug. 1, 2016

Regulation FD - July 21, 2016

Elite Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - July 21, 2016

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss SequestOx™ Complete Response Letter on Monday, July 18, 2016 at 8:30 AM EDT - July 16, 2016

FDA Issues Complete Response Letter for SequestOx™ New Drug Application - July 15, 2016

Elite Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - July 15, 2016

Elite Pharmaceuticals: Fda Issues Complete Response Letter For Sequestox™ New Drug Application - July 15, 2016

Elite Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - July 14, 2016

Elite Pharmaceuticals Inc. Just Received a Notice of Effectiveness - July 13, 2016

General form for registration of securities under the Securities Act of 1933 - June 27, 2016

Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 - June 15, 2016

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2016 and Provides Conference Call Information - June 15, 2016

Current report, items 2.02, 7.01, and 9.01 - June 15, 2016

Elite Pharmaceuticals Inc. Just Filed Its Annual Report: EARNINGS PER COMMO... - June 15, 2016

Elite Pharmaceuticals to Present SequestOx™ Data at the American Pain Society 35th Annual Scientific Meeting - May 9, 2016

Elite Pharmaceuticals Appoints Davis S. Caskey to Its Board of Directors - May 4, 2016

Elite Pharmaceuticals Inc. director just declared ownership of no shares of Elite Pharmaceuticals Inc. - May 4, 2016

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. GENEVA INVESTMENT MANAGEMENT OF CHICAGO LLC 401,252 N/A June 30, 2017

Elite Pharmaceuticals Inc. (ELTP)

140

cctranscripts

Feb. 9, 2018

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2018 Ended December 31, 2017 http://www.otcmarkets.com/stock/ELTP/news?id=183005

cctranscripts

Feb. 9, 2018

Elite Pharmaceuticals, Inc. Reports Financial Results For The Third Quarter Of Fiscal Year 2018 http://www.conferencecalltranscripts.org/pink/summary?id=4582130

cctranscripts

Feb. 8, 2018

Elite Pharmaceuticals and SunGen Pharma File ANDA http://www.otcmarkets.com/stock/ELTP/news?id=182906

cctranscripts

Feb. 8, 2018

Elite Pharmaceuticals And Sungen Pharma File Anda http://www.conferencecalltranscripts.org/pink/summary?id=4570230

cctranscripts

Feb. 7, 2018

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Third Quarter Financial Results on February 12, 2018 http://www.otcmarkets.com/stock/ELTP/news?id=182733

cctranscripts

Jan. 31, 2018

Elite Pharmaceuticals Reports Positive Topline Results From Sequestox™ Pilot Study http://www.conferencecalltranscripts.org/pink/summary?id=4538839

cctranscripts

Jan. 10, 2018

Elite Pharmaceuticals Reports Positive Topline Results From Pivotal Bioequivalence Studies For An Extended-Release Generic http://www.conferencecalltranscripts.org/pink/summary?id=4483423

cctranscripts

Jan. 10, 2018

Elite Pharmaceuticals Reports Positive Topline Results from Pivotal Bioequivalence Studies for an Extended-Release Generic http://www.otcmarkets.com/stock/ELTP/news?id=180032

cctranscripts

Jan. 2, 2018

Elite Pharmaceuticals Announces Fda Approval Of Phendimetrazine Tartrate Tablets Usp http://www.conferencecalltranscripts.org/pink/summary?id=4458983

cctranscripts

Jan. 2, 2018

Elite Pharmaceuticals Announces FDA Approval of Phendimetrazine Tartrate Tablets USP http://www.otcmarkets.com/stock/ELTP/news?id=179332

cctranscripts

Dec. 19, 2017

On December http://www.conferencecalltranscripts.org/pink/summary?id=4430190

cctranscripts

Nov. 9, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2018 Ended September 30, 2017 http://www.otcmarkets.com/stock/ELTP/news?id=174871

cctranscripts

Nov. 9, 2017

Elite Pharmaceuticals Inc. Just Filed Its Quarterly Report: NOTE 22. SUBSEQUE... http://www.conferencecalltranscripts.org/pink/summary?id=4310566

cctranscripts

Nov. 9, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results For The Second Quarter Of Fiscal Year 2018 http://www.conferencecalltranscripts.org/pink/summary?id=4307951

cctranscripts

Nov. 7, 2017

CORRECTING and REPLACING – Elite Pharmaceuticals, Inc. http://www.otcmarkets.com/stock/ELTP/news?id=174521

cctranscripts

Nov. 7, 2017

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Second Quarter Financial Results on September 10, 2017 http://www.otcmarkets.com/stock/ELTP/news?id=174476

cctranscripts

Oct. 11, 2017

Confidential treatment order http://www.conferencecalltranscripts.org/pink/summary?id=4216257

cctranscripts

Sept. 20, 2017

Elite Pharmaceuticals Files ANDA for Oxycodone Hydrochloride Extended Release http://www.otcmarkets.com/stock/ELTP/news?id=170291

cctranscripts

Sept. 7, 2017

Caution Concerning Forward Looking http://www.conferencecalltranscripts.org/pink/summary?id=4127188

cctranscripts

Aug. 30, 2017

Elite Pharmaceuticals to Present ELI-200 (SequestOx™) Data at PAINWeek 2017 National Conference http://www.otcmarkets.com/stock/ELTP/news?id=168535
 


Feedback